New daily pill shows promise for obesity and diabetes in early trial
Disease control
Completed
This early-phase study tested an oral tablet called ecnoglutide in 87 healthy adults. The drug is a GLP-1 analogue, similar to existing injectable treatments for type 2 diabetes and obesity, but designed to be taken by mouth. The main goal was to check safety and how the body pro…
Phase: PHASE1 • Sponsor: Sciwind Biosciences APAC CO Pty. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:27 UTC